VITAF — Pharmaceutical Centre SA Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Pharmaceutical Centre SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 3.17 | 3.43 | 3.67 | 3.73 | 2.22 |
| Depreciation | |||||
| Non-Cash Items | 0.222 | 0.032 | 0.341 | 0.835 | 0.315 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.97 | -1.6 | -3.66 | -1.38 | -0.469 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.589 | 2.07 | 0.557 | 3.42 | 2.32 |
| Capital Expenditures | -0.07 | -1.98 | -0.374 | -2.1 | -0.802 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.803 | 0 | 0 | 0.001 | 1.43 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.872 | -1.98 | -0.374 | -2.1 | 0.63 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.18 | -0.074 | 1.05 | -3.99 | -2.86 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.47 | 0.009 | 1.23 | -2.66 | 0.089 |